There is a 96% risk reduction for reinfarction (95% confidence interval: 61%-99%) in patients treated by PICSO compared to control patients if reperfusion time is adjusted. In addition a 86% reduction of the risk to suffer major adverse cardiac events (MACE) can be observed (95% confidence interval: 48%-96%) in patients treated by PICSO compared to control patients after adjustment of the time until reperfusion.